# Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial

> **NCT01011335** · PHASE1,PHASE2 · COMPLETED · sponsor: **Henry M. Jackson Foundation for the Advancement of Military Medicine** · enrollment: 176 (actual)

## Conditions studied

- Staphylococcus Aureus

## Interventions

- **BIOLOGICAL:** Monovalent rAT
- **BIOLOGICAL:** Monovalent rLukS-PV
- **BIOLOGICAL:** Bivalent rLukS-PV / rAT
- **BIOLOGICAL:** Placebo with adjuvant
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01011335
- **Lead sponsor:** Henry M. Jackson Foundation for the Advancement of Military Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2023-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01011335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01011335, "Staphylococcus Aureus Toxoids Phase 1-2 Vaccine Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01011335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*